The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation
10.1038/nsmb.2207
Crossref journal-article
Springer Science and Business Media LLC
Nature Structural & Molecular Biology (297)
Bibliography

Anczuków, O., Rosenberg, A. Z., Akerman, M., Das, S., Zhan, L., Karni, R., Muthuswamy, S. K., & Krainer, A. R. (2012). The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation. Nature Structural & Molecular Biology, 19(2), 220–228.

Authors 8
  1. Olga Anczuków (first)
  2. Avi Z Rosenberg (additional)
  3. Martin Akerman (additional)
  4. Shipra Das (additional)
  5. Lixing Zhan (additional)
  6. Rotem Karni (additional)
  7. Senthil K Muthuswamy (additional)
  8. Adrian R Krainer (additional)
References 60 Referenced 359
  1. Wang, E.T. et al. Alternative isoform regulation in human tissue transcriptomes. Nature 456, 470–476 (2008). (10.1038/nature07509) / Nature by ET Wang (2008)
  2. Cartegni, L., Chew, S.L. & Krainer, A.R. Listening to silence and understanding nonsense: exonic mutations that affect splicing. Nat. Rev. Genet. 3, 285–298 (2002). (10.1038/nrg775) / Nat. Rev. Genet. by L Cartegni (2002)
  3. Mayeda, A. & Krainer, A.R. Regulation of alternative pre-mRNA splicing by hnRNP A1 and splicing factor SF2. Cell 68, 365–375 (1992). (10.1016/0092-8674(92)90477-T) / Cell by A Mayeda (1992)
  4. Cáceres, J.F., Stamm, S., Helfman, D.M. & Krainer, A.R. Regulation of alternative splicing in vivo by overexpression of antagonistic splicing factors. Science 265, 1706–1709 (1994). (10.1126/science.8085156) / Science by JF Cáceres (1994)
  5. Srebrow, A. & Kornblihtt, A.R. The connection between splicing and cancer. J. Cell Sci. 119, 2635–2641 (2006). (10.1242/jcs.03053) / J. Cell Sci. by A Srebrow (2006)
  6. Ghigna, C., Moroni, M., Porta, C., Riva, S. & Biamonti, G. Altered expression of heterogenous nuclear ribonucleoproteins and SR factors in human colon adenocarcinomas. Cancer Res. 58, 5818–5824 (1998). / Cancer Res. by C Ghigna (1998)
  7. Fischer, D.C. et al. Expression of splicing factors in human ovarian cancer. Oncol. Rep. 11, 1085–1090 (2004). / Oncol. Rep. by DC Fischer (2004)
  8. He, X., Ee, P.L., Coon, J.S. & Beck, W.T. Alternative splicing of the multidrug resistance protein 1/ATP binding cassette transporter subfamily gene in ovarian cancer creates functional splice variants and is associated with increased expression of the splicing factors PTB and SRp20. Clin. Cancer Res. 10, 4652–4660 (2004). (10.1158/1078-0432.CCR-03-0439) / Clin. Cancer Res. by X He (2004)
  9. Stickeler, E., Kittrell, F., Medina, D. & Berget, S.M. Stage-specific changes in SR splicing factors and alternative splicing in mammary tumorigenesis. Oncogene 18, 3574–3582 (1999). (10.1038/sj.onc.1202671) / Oncogene by E Stickeler (1999)
  10. Zhang, Z. & Krainer, A.R. Involvement of SR proteins in mRNA surveillance. Mol. Cell 16, 597–607 (2004). (10.1016/j.molcel.2004.10.031) / Mol. Cell by Z Zhang (2004)
  11. Huang, Y., Gattoni, R., Stévenin, J. & Steitz, J.A. SR splicing factors serve as adapter proteins for TAP-dependent mRNA export. Mol. Cell 11, 837–843 (2003). (10.1016/S1097-2765(03)00089-3) / Mol. Cell by Y Huang (2003)
  12. Michlewski, G., Sanford, J.R. & Cáceres, J.F. The splicing factor SF2/ASF regulates translation initiation by enhancing phosphorylation of 4E–BP1. Mol. Cell 30, 179–189 (2008). (10.1016/j.molcel.2008.03.013) / Mol. Cell by G Michlewski (2008)
  13. Sanford, J.R., Gray, N.K., Beckmann, K. & Cáceres, J.F. A novel role for shuttling SR proteins in mRNA translation. Genes Dev. 18, 755–768 (2004). (10.1101/gad.286404) / Genes Dev. by JR Sanford (2004)
  14. Sun, S., Zhang, Z., Sinha, R., Karni, R. & Krainer, A.R. SF2/ASF autoregulation involves multiple layers of post-transcriptional and translational control. Nat. Struct. Mol. Biol. 17, 306–312 (2010). (10.1038/nsmb.1750) / Nat. Struct. Mol. Biol. by S Sun (2010)
  15. Karni, R. et al. The gene encoding the splicing factor SF2/ASF is a proto-oncogene. Nat. Struct. Mol. Biol. 14, 185–193 (2007). (10.1038/nsmb1209) / Nat. Struct. Mol. Biol. by R Karni (2007)
  16. Pind, M.T. & Watson, P.H. SR protein expression and CD44 splicing pattern in human breast tumours. Breast Cancer Res. Treat. 79, 75–82 (2003). (10.1023/A:1023338718974) / Breast Cancer Res. Treat. by MT Pind (2003)
  17. Watermann, D.O. et al. Splicing factor Tra2-beta1 is specifically induced in breast cancer and regulates alternative splicing of the CD44 gene. Cancer Res. 66, 4774–4780 (2006). (10.1158/0008-5472.CAN-04-3294) / Cancer Res. by DO Watermann (2006)
  18. Sinclair, C.S., Rowley, M., Naderi, A. & Couch, F.J. The 17q23 amplicon and breast cancer. Breast Cancer Res. Treat. 78, 313–322 (2003). (10.1023/A:1023081624133) / Breast Cancer Res. Treat. by CS Sinclair (2003)
  19. Deugnier, M.A. et al. Isolation of mouse mammary epithelial progenitor cells with basal characteristics from the Comma-Dbeta cell line. Dev. Biol. 293, 414–425 (2006). (10.1016/j.ydbio.2006.02.007) / Dev. Biol. by MA Deugnier (2006)
  20. Zhan, L. et al. Deregulation of scribble promotes mammary tumorigenesis and reveals a role for cell polarity in carcinoma. Cell 135, 865–878 (2008). (10.1016/j.cell.2008.09.045) / Cell by L Zhan (2008)
  21. Debnath, J. & Brugge, J.S. Modelling glandular epithelial cancers in three-dimensional cultures. Nat. Rev. Cancer 5, 675–688 (2005). (10.1038/nrc1695) / Nat. Rev. Cancer by J Debnath (2005)
  22. Cáceres, J.F., Misteli, T., Screaton, G.R., Spector, D.L. & Krainer, A.R. Role of the modular domains of SR proteins in subnuclear localization and alternative splicing specificity. J. Cell Biol. 138, 225–238 (1997). (10.1083/jcb.138.2.225) / J. Cell Biol. by JF Cáceres (1997)
  23. Wu, H. et al. A splicing-independent function of SF2/ASF in microRNA processing. Mol. Cell 38, 67–77 (2010). (10.1016/j.molcel.2010.02.021) / Mol. Cell by H Wu (2010)
  24. Muthuswamy, S.K., Li, D., Lelievre, S., Bissell, M.J. & Brugge, J.S. ErbB2, but not ErbB1, reinitiates proliferation and induces luminal repopulation in epithelial acini. Nat. Cell Biol. 3, 785–792 (2001). (10.1038/ncb0901-785) / Nat. Cell Biol. by SK Muthuswamy (2001)
  25. Debnath, J. et al. The role of apoptosis in creating and maintaining luminal space within normal and oncogene-expressing mammary acini. Cell 111, 29–40 (2002). (10.1016/S0092-8674(02)01001-2) / Cell by J Debnath (2002)
  26. Karni, R., Hippo, Y., Lowe, S.W. & Krainer, A.R. The splicing-factor oncoprotein SF2/ASF activates mTORC1. Proc. Natl. Acad. Sci. USA 105, 15323–15327 (2008). (10.1073/pnas.0801376105) / Proc. Natl. Acad. Sci. USA by R Karni (2008)
  27. Ghigna, C. et al. Cell motility is controlled by SF2/ASF through alternative splicing of the Ron protooncogene. Mol. Cell 20, 881–890 (2005). (10.1016/j.molcel.2005.10.026) / Mol. Cell by C Ghigna (2005)
  28. Ge, K. et al. Mechanism for elimination of a tumor suppressor: aberrant splicing of a brain-specific exon causes loss of function of Bin1 in melanoma. Proc. Natl. Acad. Sci. USA 96, 9689–9694 (1999). (10.1073/pnas.96.17.9689) / Proc. Natl. Acad. Sci. USA by K Ge (1999)
  29. Scheper, G.C. et al. The N and C termini of the splice variants of the human mitogen-activated protein kinase-interacting kinase Mnk2 determine activity and localization. Mol. Cell. Biol. 23, 5692–5705 (2003). (10.1128/MCB.23.16.5692-5705.2003) / Mol. Cell. Biol. by GC Scheper (2003)
  30. Reginato, M.J. et al. Bim regulation of lumen formation in cultured mammary epithelial acini is targeted by oncogenes. Mol. Cell. Biol. 25, 4591–4601 (2005). (10.1128/MCB.25.11.4591-4601.2005) / Mol. Cell. Biol. by MJ Reginato (2005)
  31. O'Connor, L. et al. Bim: a novel member of the Bcl-2 family that promotes apoptosis. EMBO J. 17, 384–395 (1998). (10.1093/emboj/17.2.384) / EMBO J. by L O'Connor (1998)
  32. Mami, U., Miyashita, T., Shikama, Y., Tadokoro, K. & Yamada, M. Molecular cloning and characterization of six novel isoforms of human Bim, a member of the proapoptotic Bcl-2 family. FEBS Lett. 509, 135–141 (2001). (10.1016/S0014-5793(01)03145-3) / FEBS Lett. by U Mami (2001)
  33. Cáceres, J.F. & Krainer, A.R. Functional analysis of pre-mRNA splicing factor SF2/ASF structural domains. EMBO J. 12, 4715–4726 (1993). (10.1002/j.1460-2075.1993.tb06160.x) / EMBO J. by JF Cáceres (1993)
  34. Cazalla, D. et al. Nuclear export and retention signals in the RS domain of SR proteins. Mol. Cell. Biol. 22, 6871–6882 (2002). (10.1128/MCB.22.19.6871-6882.2002) / Mol. Cell. Biol. by D Cazalla (2002)
  35. Pedraza-Fariña, L.G. Mechanisms of oncogenic cooperation in cancer initiation and metastasis. Yale J. Biol. Med. 79, 95–103 (2006). / Yale J. Biol. Med. by LG Pedraza-Fariña (2006)
  36. Hynes, N.E. & Stoelzle, T. Key signalling nodes in mammary gland development and cancer: Myc. Breast Cancer Res. 11, 210 (2009). (10.1186/bcr2406) / Breast Cancer Res. by NE Hynes (2009)
  37. Lee, E.Y. & Muller, W.J. Oncogenes and tumor suppressor genes. Cold Spring Harb. Perspect. Biol. 2, a003236 (2010). / Cold Spring Harb. Perspect. Biol. by EY Lee (2010)
  38. Lin, C.J., Cencic, R., Mills, J.R., Robert, F. & Pelletier, J. c-Myc and eIF4F are components of a feedforward loop that links transcription and translation. Cancer Res. 68, 5326–5334 (2008). (10.1158/0008-5472.CAN-07-5876) / Cancer Res. by CJ Lin (2008)
  39. Ruggero, D. et al. The translation factor eIF-4E promotes tumor formation and cooperates with c-Myc in lymphomagenesis. Nat. Med. 10, 484–486 (2004). (10.1038/nm1042) / Nat. Med. by D Ruggero (2004)
  40. Miao, J. et al. Identification and characterization of BH3 domain protein Bim and its isoforms in human hepatocellular carcinomas. Apoptosis 12, 1691–1701 (2007). (10.1007/s10495-007-0093-5) / Apoptosis by J Miao (2007)
  41. Schwerk, C. & Schulze-Osthoff, K. Regulation of apoptosis by alternative pre-mRNA splicing. Mol. Cell 19, 1–13 (2005). (10.1016/j.molcel.2005.05.026) / Mol. Cell by C Schwerk (2005)
  42. Moore, M.J., Wang, Q., Kennedy, C.J. & Silver, P.A. An alternative splicing network links cell-cycle control to apoptosis. Cell 142, 625–636 (2010). (10.1016/j.cell.2010.07.019) / Cell by MJ Moore (2010)
  43. Li, X., Wang, J. & Manley, J.L. Loss of splicing factor ASF/SF2 induces G2 cell cycle arrest and apoptosis, but inhibits internucleosomal DNA fragmentation. Genes Dev. 19, 2705–2714 (2005). (10.1101/gad.1359305) / Genes Dev. by X Li (2005)
  44. Inoki, K., Corradetti, M.N. & Guan, K.L. Dysregulation of the TSC-mTOR pathway in human disease. Nat. Genet. 37, 19–24 (2005). (10.1038/ng1494) / Nat. Genet. by K Inoki (2005)
  45. Lazaris-Karatzas, A., Montine, K.S. & Sonenberg, N. Malignant transformation by a eukaryotic initiation factor subunit that binds to mRNA 5′ cap. Nature 345, 544–547 (1990). (10.1038/345544a0) / Nature by A Lazaris-Karatzas (1990)
  46. Topisirovic, I., Ruiz-Gutierrez, M. & Borden, K.L. Phosphorylation of the eukaryotic translation initiation factor eIF4E contributes to its transformation and mRNA transport activities. Cancer Res. 64, 8639–8642 (2004). (10.1158/0008-5472.CAN-04-2677) / Cancer Res. by I Topisirovic (2004)
  47. Dowling, R.J. et al. mTORC1-mediated cell proliferation, but not cell growth, controlled by the 4E-BPs. Science 328, 1172–1176 (2010). (10.1126/science.1187532) / Science by RJ Dowling (2010)
  48. Ngo, J.C. et al. A sliding docking interaction is essential for sequential and processive phosphorylation of an SR protein by SRPK1. Mol. Cell 29, 563–576 (2008). (10.1016/j.molcel.2007.12.017) / Mol. Cell by JC Ngo (2008)
  49. Tintaru, A.M. et al. Structural and functional analysis of RNA and TAP binding to SF2/ASF. EMBO Rep. 8, 756–762 (2007). (10.1038/sj.embor.7401031) / EMBO Rep. by AM Tintaru (2007)
  50. Zuo, P. & Manley, J.L. Functional domains of the human splicing factor ASF/SF2. EMBO J. 12, 4727–4737 (1993). (10.1002/j.1460-2075.1993.tb06161.x) / EMBO J. by P Zuo (1993)
  51. Cáceres, J.F., Screaton, G.R. & Krainer, A.R. A specific subset of SR proteins shuttles continuously between the nucleus and the cytoplasm. Genes Dev. 12, 55–66 (1998). (10.1101/gad.12.1.55) / Genes Dev. by JF Cáceres (1998)
  52. Shaw, S.D., Chakrabarti, S., Ghosh, G. & Krainer, A.R. Deletion of the N-terminus of SF2/ASF permits RS-domain-independent pre-mRNA splicing. PLoS ONE 2, e854 (2007). (10.1371/journal.pone.0000854) / PLoS ONE by SD Shaw (2007)
  53. Yu, Q., Geng, Y. & Sicinski, P. Specific protection against breast cancers by cyclin D1 ablation. Nature 411, 1017–1021 (2001). (10.1038/35082500) / Nature by Q Yu (2001)
  54. Li, S. et al. Translation factor eIF4E rescues cells from Myc-dependent apoptosis by inhibiting cytochrome c release. J. Biol. Chem. 278, 3015–3022 (2003). (10.1074/jbc.M208821200) / J. Biol. Chem. by S Li (2003)
  55. Mao, D.Y. et al. Analysis of Myc bound loci identified by CpG island arrays shows that Max is essential for Myc-dependent repression. Curr. Biol. 13, 882–886 (2003). (10.1016/S0960-9822(03)00297-5) / Curr. Biol. by DY Mao (2003)
  56. Das, S., Anczuków, O., Akerman, M. & Krainer, A.R. SRSF1 is a critical transcriptional target of MYC. Cell Rep. (in the press). (10.1016/j.celrep.2011.12.001)
  57. Elliott, K. et al. Bin1 functionally interacts with Myc and inhibits cell proliferation through multiple mechanisms. Oncogene 18, 3564–3573 (1999). (10.1038/sj.onc.1202670) / Oncogene by K Elliott (1999)
  58. Sakamuro, D., Elliott, K.J., Wechsler-Reya, R. & Prendergast, G.C. BIN1 is a novel MYC-interacting protein with features of a tumour suppressor. Nat. Genet. 14, 69–77 (1996). (10.1038/ng0996-69) / Nat. Genet. by D Sakamuro (1996)
  59. Debnath, J., Muthuswamy, S.K. & Brugge, J.S. Morphogenesis and oncogenesis of MCF-10A mammary epithelial acini grown in three-dimensional basement membrane cultures. Methods 30, 256–268 (2003). (10.1016/S1046-2023(03)00032-X) / Methods by J Debnath (2003)
  60. Spancake, K.M. et al. E7-transduced human breast epithelial cells show partial differentiation in three-dimensional culture. Cancer Res. 59, 6042–6045 (1999). / Cancer Res. by KM Spancake (1999)
Dates
Type When
Created 13 years, 7 months ago (Jan. 15, 2012, 2:11 p.m.)
Deposited 2 years, 3 months ago (May 19, 2023, 12:30 a.m.)
Indexed 2 days, 23 hours ago (Aug. 21, 2025, 1:59 p.m.)
Issued 13 years, 7 months ago (Jan. 15, 2012)
Published 13 years, 7 months ago (Jan. 15, 2012)
Published Online 13 years, 7 months ago (Jan. 15, 2012)
Published Print 13 years, 6 months ago (Feb. 1, 2012)
Funders 0

None

@article{Anczuk_w_2012, title={The splicing factor SRSF1 regulates apoptosis and proliferation to promote mammary epithelial cell transformation}, volume={19}, ISSN={1545-9985}, url={http://dx.doi.org/10.1038/nsmb.2207}, DOI={10.1038/nsmb.2207}, number={2}, journal={Nature Structural & Molecular Biology}, publisher={Springer Science and Business Media LLC}, author={Anczuków, Olga and Rosenberg, Avi Z and Akerman, Martin and Das, Shipra and Zhan, Lixing and Karni, Rotem and Muthuswamy, Senthil K and Krainer, Adrian R}, year={2012}, month=jan, pages={220–228} }